Mehdi H. Hamadani, MD

Professor and Cancer Center Scholar Endowed Chair; Chief, Section of Hematologic Malignancies/BMT; Co-Associate Director of Clinical Research


  • Cancer Center - Froedtert Hospital
  • 8800 West Doyne Ave.
  • Milwaukee, WI 53226


  • Hematology
  • Medical Oncology

Cancer Center - Froedtert Hospital

Moorland Reserve Health Center


Diseases and Conditions

  • Hodgkin's Lymphoma (Hodgkin's Disease)
  • Leukemia
  • Multiple Myeloma
  • Myelodysplastic Syndromes (MDS)
  • Non Hodgkin's Lymphoma

Treatments and Services

  • Bone Marrow Transplantation (BMT)
  • Autologous Transplantation
  • Allogeneic Transplantation
  • Alternative Donor Transplant
  • CAR T-Cell Therapy
  • Virtual Visit

Patients Ages Seen

  • Adult
  • Senior


  • English
  • Urdu
  • Hindi
  • Punjabi

Hospital Affiliations

  • Froedtert Hospital – Milwaukee

Board Certifications

  • Internal Medicine
  • Hematology
  • Medical Oncology

Clinic Locations


Dr. Hamadani is a Professor of Medicine and Chief of Hematologic Malignancies at the Medical College of Wisconsin (MCW) in Milwaukee, WI. He serves as the Co-Associate Director of Clinical Research at the MCW Clinical Cancer Center and holds the Cancer Center Scholar Endowed Chair. Dr. Hamadani graduated with honors from King Edward Medical College (Pakistan), in 2001. He completed internal medicine residency from the University of Oklahoma followed by a fellowship in Hematology/Oncology at The Ohio State University. He is considered an international key opinion leader in the fields of hematopoietic cell transplantation, cellular therapy and lymphoid malignancies. He has authored over 400 peer-reviewed publications. As the Principal Protocol Officer for BMT CTN Network he has extensive experience in clinical trial design and has been involved in the development and execution of several practice changing transplant clinical trials. He chairs the ASTCT Committee on Practice Guidelines and Serves as the Secretary of American Society for Transplant and Cellular Therapies (2024-26). His key areas of search include graft-versus-host disease (GvHD), developmental therapeutics for lymphoid malignancies and hematopoietic cell transplantation. His clinical expertise includes lymphomas, transplant, and CAR-T cell therapies. He considers mentoring junior faculty and trainees as his top-most priority.

Education and Training

Doctor of Medicine - King Edward Medical College - Lahore (2001)
Internship in Internal Medicine - University of Oklahoma Health Sciences Center - Oklahoma City, OK (2003-2004)
Residency in Internal Medicine - University of Oklahoma Health Sciences Center - Oklahoma City, OK (2003-2004)
Fellowship In Hematology and Oncology - Arthur G. James Cancer Hospital and Research Institute - Columbus, OH (2006-2009)